Results 131 to 140 of about 10,600 (216)

Real-world Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in ≥50-year-old Adults With Autoimmune Diseases. [PDF]

J Infect Dis
Constenla D, Lonnet G, Aris E, Rk R, Servotte N, Mwakingwe-Omari A, Alsdurf H, Yun H.   +7 more
europepmc   +1 more source

Safety profile of the adjuvanted recombinant zoster vaccine

The ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229) phase 3 clinical trials showed that the adjuvanted recombinant zoster vaccine (RZV) was ≥90% efficacious in preventing herpes zoster in adults. Here we present a comprehensive overview of the safety data from these studies.
López Fauqued, Marta||, Campora, Laura, Delannois, Frédérique, El Idrissi, Mohamed||, Oostvogels, Lidia||, De Looze, Ferdinandus||, Diez-Domingo, Javier||, Heineman, Thomas||, Lal, Himal, McElhaney, Janet||, McNeil, Shelly||, Yeo, Wilfred||, Tavares-Da-Silva, Fernanda||, Ahonen, Anitta, Avelino-Silva, Thiago||, Barba-Gomez, José Fernando, Berglund, Johan||, Brotons, Carlos||, Caso, Covadonga, Chlibek, Roman, Choi, Won Suk||, Cunningham, Anthony||, Desole, Maria Giuseppina, Eizenberg, Peter, Esen, Meral, Espié, Emmanuelle, Gervais, Pierre, Ghesquiere, Wayne, Godeaux, Olivier O., Gorfinkel, Iris, Hui, David Shu Cheong, Hwang, Shinnjang, Korhonen, Tiina, Kovac, Martina||, Ledent, Edouard Y., Leung, Edward Man Fuk, Levin, Myron||, Perez, Silvia Narejos, de Andrade Neto, José Luiz, Pauksens, Karlis, Poder, Airi, Rodriguez de la Pinta, Maria Luisa||, Rombo, Lars, Schwarz, Tino Francis, Smetana, Jan||, Staniscia, Tommaso||, Tinoco-Fávila, Juan Carlos, Toma, Azhar, Vastiau, Ilse, Vesikari, Timo H., Volpi, Antonio, Watanabe, Daisuke||, Weckx, Lily||, Zahaf, Toufik||   +53 more
openaire   +1 more source

Real-world study: Analysis of post-marketing safety for recombinant zoster vaccine in Shandong, China. [PDF]

Hum Vaccin Immunother
Li H, Xie M, Qiu X, Kang X, Li F, Xu A, Zhang L.   +6 more
europepmc   +1 more source

Effectiveness and Safety of Recombinant Zoster Vaccine in Rheumatic Diseases: Real-World Evidence from a Single-Centre Italian Cohort. [PDF]

Vaccines (Basel)
Valentini S, Sota J, Fineschi I, Conticini E, Garcia-Gonzalez E, D'Ignazio E, Bardelli M, Gentileschi S, Fabbroni M, Bellisai F, Falsetti P, Selvi E, Cantarini L, Frediani B, Baldi C.   +14 more
europepmc   +1 more source

Effectiveness and safety of recombinant zoster vaccine: A review of real-world evidence. [PDF]

Hum Vaccin Immunother, 2023
Parikh R, Singer D, Chmielewski-Yee E, Dessart C.   +3 more
europepmc   +1 more source

Risk of autoimmune disease flares after recombinant zoster vaccine: A vaccine safety analysis based on the Vaccine Adverse Event Reporting System database. [PDF]

Hum Vaccin Immunother
Liu G, Zhang X, Wang Y, Wang Y, He P, Yu Q.   +5 more
europepmc   +1 more source

Skin manifestations after immunisation with an adjuvanted recombinant zoster vaccine, Germany, 2020. [PDF]

Euro Surveill, 2023
Orru' S, Bierbaum S, Enk A, Hengel H, Hoffelner M, Huzly D, Keller-Stanislawski B, Mahler V, Mockenhaupt M, Oberle D.   +9 more
europepmc   +1 more source

The safety of co-administration of recombinant zoster vaccine (Shingrix) and influenza vaccines in the elderly in VAERS during 2018-2024. [PDF]

Hum Vaccin Immunother
Li Y, Xia H, Zhang H, Lu Y, Zhou H, Yu R, Huang P.   +6 more
europepmc   +1 more source

Adjuvanted Recombinant Zoster Vaccine is Effective Against Herpes Zoster Ophthalmicus, and is Associated With Lower Risk of Acute Myocardial Infarction and Stroke in Adults Aged ≥50 Years. [PDF]

Clin Infect Dis
Rayens E, Sy LS, Qian L, Wu J, Ackerson BK, Luo Y, Zheng C, Cheng Y, Vega Daily LI, Song J, Takhar HS, Ku JH, Cohen RA, Yun H, Oraichi D, Seifert H, Tseng HF.   +16 more
europepmc   +1 more source

Recombinant Zoster Vaccine Use to Prevent Recurrent Shingles in an Adolescent Renal Transplant Recipient. [PDF]

Cureus
Nikfarjam N, Grimm P.
europepmc   +1 more source